Abivax reports Phase 3 maintenance trial results for obefazimod

June 29, 2026 4:06 PM

Abivax SA (Euronext Paris: ABVX / Nasdaq: ABVX) reported topline results from ABTECT Maintenance Part 2, a supplemental portion of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found